Oral mucosal absorption study of Bicalutamide new formulation

Study identifier:D6874L00016

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Terminated/Withdrawn

Official Title

Oral mucosal absorption study of ICI176,334-1 (Bicalutamide new formulation) in Japanese healthy male subjects

Medical condition

Healthy

Phase

Phase 1

Healthy volunteers

Yes

Study drug

ICI176,334-1

Sex

Male

Actual Enrollment

8

Study type

Interventional

Age

20 Years - 45 Years

Date

Study Start Date: 01 Jul 2010
Primary Completion Date: 01 Aug 2010
Study Completion Date: 01 Aug 2010

Study design

Allocation: Non-randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria